|
TRIOC: A randomised parallel group double-blind phase II study to assess the activity of MVA-5T4 vaccine versus placebo in patients with relapsed asymptomatic epithelial ovarian, fallopian tube, or primary peritoneal cancer. |
|
|
Travel, Accommodations, Expenses - Astellas Pharma; Pfizer; Roche |
|
|
Honoraria - AstraZeneca; Roche |
Consulting or Advisory Role - AstraZeneca; Roche/Genentech |
|
|
Consulting or Advisory Role - Philips Healthcare |
Research Funding - Philips Healthcare |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Healthcare at Home |
|
|
Honoraria - Astron Research Ltd; Roche |
Consulting or Advisory Role - AstraZeneca; Roche |
Research Funding - AstraZeneca |
|
|
Consulting or Advisory Role - AstraZeneca |
Research Funding - AB Science; Amgen; Array BioPharma; AstraZeneca; Clovis Oncology |
|
Rebecca Sophie Kristeleit |
Honoraria - AstraZeneca; Clovis Oncology; Roche/Genentech |
Consulting or Advisory Role - Clovis Oncology; Lytix Biopharma; Roche/Genentech; Sotio |
Travel, Accommodations, Expenses - Basilea; Clovis Oncology; PiQuR |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - AstraZeneca; Clovis Oncology |
|
|
Employment - Oxford Biomedica |
Stock and Other Ownership Interests - Oxford Biomedica |
Patents, Royalties, Other Intellectual Property - Oxford Biomedica |
Travel, Accommodations, Expenses - Oxford Biomedica |
|
|
Consulting or Advisory Role - AstraZeneca/MedImmune (Inst); Clovis Oncology (Inst) |
Research Funding - AstraZeneca (Inst) |